Sunday, March 25, 2012

Global Nephrology: Dialysis in the UK – "A Case of the Fox Guarding the Henhouse"?

I’ve been in London for the past week or so. I came across the following story on the BBC on March 22 about Fresenius laying off 29 health care assistants redundant across the West Midlands. In the report Dr Nick Richards, Fresenius' medical director, says that overall, patient-care is "exactly the same". The spokesperson for the University Hospitals Birmingham NHS Foundation Trust says: "We have been informed that Fresenius are implementing a staff reduction programme at Aston Cross, City, Hereford, Tipton and Kings Norton dialysis units….We will continue to closely monitor the service delivered to ensure that Fresenius uphold the standard of care required in accordance with the terms of the contract."

In January a similar story about a Fresenius clinic in Sheffield cutting evening shifts, also reported by the BBC.

Fresenius Medical Care is the largest independent provider of dialysis care in the UK with over 50 dialysis clinics. They are well aware that cutting health care assistants and access to evening dialysis services won’t improve dialysis quality, and if anything, will make things worse. After all, not being able to provide evening services is likely to affect younger patients’ who work and then have dialysis. Getting rid of staff in the name of efficiency is all very well when you're operating a factory but in my experience it doesn't translate well in health services.

While the UK does publish its unit specific dialysis outcome data, unlike the USRDS it doesn’t identify the dialysis provider. Still, I am sure that with some effort one could do an analysis to see if the units that have been affected by the cutbacks have had a reduction in one or more quality metrics. I hope the NHS scrutinizes whatever provider specific data it has very carefully.

In the US where across-the-board reduction in patient-nursing staff ratios have occurred over the past decade it’s still hard to figure out whether this has affected outcome because quality of life data by patients is not reported. The data we do have is that for mortality and dialysis treatment time; the "for-profits" lag behind "not-for-profits" and more generally, the US lags behind Europe and Japan.

My bottom line: When a dialysis provider cuts services by laying off staff I would ask is this another case of "the fox guarding the henhouse"?